Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more
- PMID: 21427396
- DOI: 10.1093/cid/cir076
Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more
Abstract
Sustained virologic response (SVR) is defined as aviremia 24 weeks after completion of antiviral therapy for chronic hepatitis C virus (HCV) infection. In analyses of SVR durability, the incidence of late relapse is extremely low (<1%). Histologic regression of both necroinflammation and fibrosis has been demonstrated in paired liver biopsy samples in SVR-achieving patients. More noteworthy is the sustained responder's favorable prognosis even with baseline cirrhosis; despite mostly retrospective analyses, relative to nonresponders or to those untreated, patients with SVR have significantly fewer liver-related complications, less hepatocellular carcinoma, and fewer liver-related deaths. Although HCV is associated with insulin resistance, successful eradication of HCV appears to reduce the risk of impaired fasting glucose and diabetes development. In summary, chronic HCV infection is curable with SVR attainment, and with cure comes improved liver histology and more favorable clinical outcomes, in comparison with patients who do not achieve the same therapeutic milestone.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Similar articles
-
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.Cancer. 1999 May 1;85(9):1943-50. Cancer. 1999. PMID: 10223234
-
Prevention of hepatocellular carcinoma complicating chronic hepatitis C.J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x. J Gastroenterol Hepatol. 2009. PMID: 19368633 Review.
-
[Chronic hepatitis C].Dtsch Med Wochenschr. 2010 Dec;135(50):2525-34; quiz 2535-8. doi: 10.1055/s-0030-1269423. Epub 2010 Dec 7. Dtsch Med Wochenschr. 2010. PMID: 21140330 Review. German.
-
A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.Clin Infect Dis. 2013 Jul;57(2):230-6. doi: 10.1093/cid/cit234. Epub 2013 Apr 24. Clin Infect Dis. 2013. PMID: 23616492
-
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.Gastroenterology. 2008 Sep;135(3):821-9. doi: 10.1053/j.gastro.2008.05.044. Epub 2008 May 21. Gastroenterology. 2008. PMID: 18593587
Cited by
-
Best strategies for global HCV eradication.Liver Int. 2013 Feb;33 Suppl 1(0 1):68-79. doi: 10.1111/liv.12063. Liver Int. 2013. PMID: 23286849 Free PMC article. Review.
-
How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study.BMC Health Serv Res. 2016 Jul 11;16:247. doi: 10.1186/s12913-016-1503-6. BMC Health Serv Res. 2016. PMID: 27402141 Free PMC article.
-
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science.Can J Public Health. 2019 Jun;110(3):376-379. doi: 10.17269/s41997-018-0164-0. Epub 2019 Jan 8. Can J Public Health. 2019. PMID: 30623357 Free PMC article.
-
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.BMJ. 2023 Aug 2;382:e074001. doi: 10.1136/bmj-2022-074001. BMJ. 2023. PMID: 37532284 Free PMC article.
-
Prognostic significance of peritumoral fibrosis after resection of pancreatic head cancer.Oncol Lett. 2020 Feb;19(2):1235-1240. doi: 10.3892/ol.2019.11181. Epub 2019 Dec 4. Oncol Lett. 2020. PMID: 32002027 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
